期刊
JOURNAL OF INFECTIOUS DISEASES
卷 198, 期 3, 页码 318-323出版社
OXFORD UNIV PRESS INC
DOI: 10.1086/589714
关键词
-
资金
- Intramural NIH HHS [Z01 AI000913-06] Funding Source: Medline
Infection with Epstein-Barr virus (EBV) results in lifelong infection of B cells in the peripheral blood and in episodic shedding of virus from the oropharynx. We monitored patients treated with rituximab (anti-CD20 monoclonal antibody) and found that several had both no detectable B cells and no EBV in the blood but shed EBV from the throat. Although some models postulate that EBV traffics from the B cells in the blood to the throat, where it is subsequently shed, our findings indicate that circulating EBV in B cells is not necessary for the virus to persist in, and to be shed from, the oropharynx.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据